Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 376

1.

Adding markers of organ damage to risk score models improves cardiovascular risk assessment: Prospective analysis of a large cohort of adult outpatients.

Tocci G, Figliuzzi I, Presta V, Attalla El Halabieh N, Citoni B, Coluccia R, Battistoni A, Ferrucci A, Volpe M.

Int J Cardiol. 2017 Dec 1;248:342-348. doi: 10.1016/j.ijcard.2017.07.078. Epub 2017 Jul 25.

PMID:
28802734
2.

A Decrease of Brain MicroRNA-122 Level Is an Early Marker of Cerebrovascular Disease in the Stroke-Prone Spontaneously Hypertensive Rat.

Stanzione R, Bianchi F, Cotugno M, Marchitti S, Forte M, Busceti C, Ryskalin L, Fornai F, Volpe M, Rubattu S.

Oxid Med Cell Longev. 2017;2017:1206420. doi: 10.1155/2017/1206420. Epub 2017 Jun 18.

3.

Pulmonary hypertension and clinical correlates in hypertrophic cardiomyopathy.

Musumeci MB, Mastromarino V, Casenghi M, Tini G, Francia P, Maruotti A, Romaniello A, Magrì D, Lillo R, Adduci C, Volpe M, Autore C.

Int J Cardiol. 2017 Dec 1;248:326-332. doi: 10.1016/j.ijcard.2017.07.010. Epub 2017 Jul 14.

PMID:
28733069
4.

Reduced brain UCP2 expression mediated by microRNA-503 contributes to increased stroke susceptibility in the high-salt fed stroke-prone spontaneously hypertensive rat.

Rubattu S, Stanzione R, Bianchi F, Cotugno M, Forte M, Della Ragione F, Fioriniello S, D'Esposito M, Marchitti S, Madonna M, Baima S, Morelli G, Sciarretta S, Sironi L, Gelosa P, Volpe M.

Cell Death Dis. 2017 Jun 22;8(6):e2891. doi: 10.1038/cddis.2017.278.

5.

Impact of Glycemic Variability on Chromatin Remodeling, Oxidative Stress, and Endothelial Dysfunction in Patients With Type 2 Diabetes and With Target HbA1c Levels.

Costantino S, Paneni F, Battista R, Castello L, Capretti G, Chiandotto S, Tanese L, Russo G, Pitocco D, Lanza GA, Volpe M, Lüscher TF, Cosentino F.

Diabetes. 2017 Sep;66(9):2472-2482. doi: 10.2337/db17-0294. Epub 2017 Jun 20.

PMID:
28634176
6.

C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP.

Carnevale R, Pignatelli P, Frati G, Nocella C, Stanzione R, Pastori D, Marchitti S, Valenti V, Santulli M, Barbato E, Strisciuglio T, Schirone L, Vecchione C, Violi F, Volpe M, Rubattu S, Sciarretta S.

Sci Rep. 2017 Jun 19;7(1):3797. doi: 10.1038/s41598-017-03679-9.

7.

Monotherapy and Dual Combination Therapies Based on Olmesartan: A Comprehensive Strategy to Improve Blood Pressure Control.

Volpe M, Santolamazza C, Mastromarino V, Coluccia R, Battistoni A, Tocci G.

High Blood Press Cardiovasc Prev. 2017 Jun 12. doi: 10.1007/s40292-017-0216-1. [Epub ahead of print] Review.

PMID:
28608026
8.

Triple Combination Therapies Based on Olmesartan: A Personalized Therapeutic Approach to Improve Blood Pressure Control.

Volpe M, Santolamazza C, Mastromarino V, Coluccia R, Battistoni A, Tocci G.

High Blood Press Cardiovasc Prev. 2017 Jun 12. doi: 10.1007/s40292-017-0217-0. [Epub ahead of print] Review.

PMID:
28608025
9.

Favourable impact of statin use on diastolic blood pressure levels: analysis of a large database of 24-hour ambulatory blood pressure monitoring.

Tocci G, Presta V, Citoni B, Figliuzzi I, Coluccia R, Battistoni A, Musumeci MB, De Biase L, Ferrucci A, Volpe M.

J Hypertens. 2017 Oct;35(10):2086-2094. doi: 10.1097/HJH.0000000000001419.

PMID:
28582284
10.

Aspirin and the Primary Prevention of Cardiovascular Diseases: An Approach Based on Individualized, Integrated Estimation of Risk.

Volpe M, Battistoni A, Gallo G, Coluccia R, De Caterina R.

High Blood Press Cardiovasc Prev. 2017 Jun 1. doi: 10.1007/s40292-017-0213-4. [Epub ahead of print]

PMID:
28573479
11.

2017 Position Paper of the Italian Society for Cardiovascular Prevention (SIPREC) for an Updated Clinical Management of Hypercholesterolemia and Cardiovascular Risk: Executive Document.

Volpe M, Volpe R, Gallo G, Presta V, Tocci G, Folco E, Peracino A, Tremoli E, Trimarco B; Italian Society of Cardiovascular Prevention (SIPREC) Writing Committee.

High Blood Press Cardiovasc Prev. 2017 May 18. doi: 10.1007/s40292-017-0211-6. [Epub ahead of print]

PMID:
28523635
12.

Attitudes and preferences for the clinical management of hypertension and hypertension-related cerebrovascular disease in the general practice: results of the Italian hypertension and brain survey.

Tocci G, Cicero AF, Salvetti M, Musumeci MB, Ferrucci A, Borghi C, Volpe M.

Clin Hypertens. 2017 May 15;23:10. doi: 10.1186/s40885-017-0066-0. eCollection 2017.

13.

Has the SPRINT trial introduced a new blood-pressure goal in hypertension?

Ruiz-Hurtado G, Banegas JR, Sarafidis PA, Volpe M, Williams B, Ruilope LM.

Nat Rev Cardiol. 2017 Sep;14(9):560-566. doi: 10.1038/nrcardio.2017.74. Epub 2017 May 11. Review.

PMID:
28492286
14.

Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future.

Mahfoud F, Schmieder RE, Azizi M, Pathak A, Sievert H, Tsioufis C, Zeller T, Bertog S, Blankestijn PJ, Böhm M, Burnier M, Chatellier G, Durand Zaleski I, Ewen S, Grassi G, Joner M, Kjeldsen SE, Lobo MD, Lotan C, Felix Lüscher T, Parati G, Rossignol P, Ruilope L, Sharif F, van Leeuwen E, Volpe M, Windecker S, Witkowski A, Wijns W.

Eur Heart J. 2017 May 5. doi: 10.1093/eurheartj/ehx215. [Epub ahead of print] No abstract available.

PMID:
28475773
15.

Hypertension Across the Atlantic: A Sprint or a Marathon?

Volpe M, Citoni B, Coluccia R, Battistoni A, Tocci G.

High Blood Press Cardiovasc Prev. 2017 Jun;24(2):99-102. doi: 10.1007/s40292-017-0203-6. Epub 2017 Apr 27. No abstract available.

PMID:
28451910
16.

Anemia and heart failure: Is there still a role for erythropoiesis-stimulating agents?

Volpe M, Mastromariona V.

Turk Kardiyol Dern Ars. 2017 Apr;45(3):217-218. doi: 10.5543/tkda.2016.50249. No abstract available.

17.

A differential expression of uncoupling protein-2 associates with renal damage in stroke-resistant spontaneously hypertensive rat/stroke-prone spontaneously hypertensive rat-derived stroke congenic lines.

Rubattu S, Cotugno M, Bianchi F, Sironi L, Gelosa P, Stanzione R, Forte M, De Sanctis C, Madonna M, Marchitti S, Pignieri A, Sciarretta S, Volpe M.

J Hypertens. 2017 Sep;35(9):1857-1871. doi: 10.1097/HJH.0000000000001374.

PMID:
28399045
18.

An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy.

Frati G, Schirone L, Chimenti I, Yee D, Biondi-Zoccai G, Volpe M, Sciarretta S.

Cardiovasc Res. 2017 Mar 15;113(4):378-388. doi: 10.1093/cvr/cvx011.

PMID:
28395009
19.

Dickkopf-3 Upregulates VEGF in Cultured Human Endothelial Cells by Activating Activin Receptor-Like Kinase 1 (ALK1) Pathway.

Busceti CL, Marchitti S, Bianchi F, Di Pietro P, Riozzi B, Stanzione R, Cannella M, Battaglia G, Bruno V, Volpe M, Fornai F, Nicoletti F, Rubattu S.

Front Pharmacol. 2017 Mar 14;8:111. doi: 10.3389/fphar.2017.00111. eCollection 2017.

20.

QT spatial dispersion and sudden cardiac death in hypertrophic cardiomyopathy: Time for reappraisal.

Magrì D, Santolamazza C, Limite L, Mastromarino V, Casenghi M, Orlando P, Pagannone E, Musumeci MB, Maruotti A, Ricotta A, Oliviero G, Piccirillo G, Volpe M, Autore C.

J Cardiol. 2017 Oct;70(4):310-315. doi: 10.1016/j.jjcc.2017.01.006. Epub 2017 Mar 22.

PMID:
28341542

Supplemental Content

Loading ...
Support Center